Navigation Links
Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits

ROCHESTER, Minn., Nov. 9 /PRNewswire-USNewswire/ -- New Mayo Clinic research has found that robotic surgery for vaginal prolapse dramatically reduces patient hospital stay and recovery time. These findings are being presented this week at the North Central Section of the American Urological Association in Scottsdale, Ariz.


VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. Daniel Elliott describing the research, are available on the Mayo Clinic News Blog.

Vaginal prolapse is a condition in which structures such as the uterus, rectum, bladder, urethra, small bowel, or the vagina itself may begin to prolapse, or fall, from their normal positions. Without treatment or surgery, these structures may eventually prolapse farther into the vagina or even through the vaginal opening if their supports weaken enough.

"Vaginal prolapse is a common, yet distressing physical and cosmetic condition that 10-15 percent of women will suffer in their lifetimes," says Daniel Elliott, M.D., Mayo Clinic urologist and senior author on the study. "Robotic sacrocolpopexy surgery appears to offer many new benefits for patients -- including decreased hospital stay and quicker recovery. Our study looked at longer-term results post-surgery to find out how patients fared."

From 2002 to 2008, 48 women with symptomatic high-grade post-hysterectomy vaginal vault prolapse underwent robotic sacrocolpopexy, or vaginal wall repair. Researchers monitored these patients for three years to evaluate the success rate of the procedure. Overall, researchers found better outcomes for robotic sacrocolpopexy patients than traditional surgery, which included: 1) less-invasive, laparoscopic surgery took less time in the operating room; 2) fewer postoperative complications; 3) shorter hospital stay; and 4) faster postoperative recovery and return to work or normal activities.

Prolapse often affects postmenopausal women who've had one or more vaginal deliveries. Damage sustained by supportive tissues during pregnancy and childbirth, plus the effects of gravity, loss of estrogen and repeated straining over the years, can weaken pelvic floor muscles and tissues and lead to uterine prolapse.

"Traditional abdominal sacrocolpopexy is a very durable procedure, but recovery is long and sometimes dissuades women from having surgery," says Dr. Elliott. "This new robotic surgery is a major improvement and offers more options for women who want to have their prolapse repaired and are looking for a less-invasive type of procedure."

Others on the Mayo research team include M.A. Childs, M.D., and George Chow, M.D.

About Mayo Clinic

Mayo Clinic is the first and largest integrated, not-for-profit group practice in the world. Doctors from every medical specialty work together to care for patients, joined by common systems and a philosophy of "the needs of the patient come first." More than 3,300 physicians, scientists and researchers and 46,000 allied health staff work at Mayo Clinic, which has sites in Rochester, Minn., Jacksonville, Fla., and Scottsdale/Phoenix, Ariz. Collectively, the three locations treat more than half a million people each year. To obtain the latest news releases from Mayo Clinic, go to For information about research and education visit is available as a resource for your health stories.

SOURCE Mayo Clinic

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain
2. Researchers show how to divide and conquer social network of cells
3. Connection between depression and osteoporosis detailed by Hebrew University researchers
4. Researchers find new way to attack inflammation in Graves eye disease
5. Jefferson researchers receive $3.9 million in Challenge grants
6. Childhood cancer survivors less likely to marry, Yale researchers find
7. Researchers unlock the sound of learning by linking sensory and motor systems
8. Researchers identify the 3 killer indicators that are even worse than high cholesterol
9. Researchers discover links between city walkability and air pollution exposure
10. High-definition colonoscopy detects more polyps, Mayo Clinic researchers say
11. Researchers find room design can enhance patient care
Post Your Comments:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: